newsfilter
← Latest News
Business Wire·

OS Therapies to Host Analyst Day at NYSE on April 7, 2025

OS Therapies (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, today announced that the Company will be hosting an Analyst Day